Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Income Statement [Abstract]    
Revenue $ 513
Operating costs and expenses:    
Inventor royalties, contingent legal fees, litigation and licensing expenses 385
Research and development expenses (including non-cash share-based compensation expenses of $1,276 and $290, respectively) 1,838 828
General and administrative expenses (including non-cash share-based compensation expenses of $1,078 and $696, respectively) 2,042 1,533
Total operating costs and expenses 3,880 2,746
Loss from operations (3,880) (2,233)
Interest income 1 1
Net loss (3,879) (2,232)
Less: Net loss attributable to noncontrolling interest (50) (24)
Net loss attributable to common shareholders $ (3,829) $ (2,208)
Net loss per common share attributable to common shareholders:    
Basic and diluted $ (0.13) $ (0.09)
Weighted average common shares outstanding:    
Basic and diluted 30,125 25,165